Clinicopathological aspects of patients with recurrence of borderline ovarian tumors

Obstetrics & Gynecology Science
Sumin OhYong-Sang Song

Abstract

Despite the good prognosis of borderline ovarian tumors (BOTs), a few BOT patients experience the relapse of disease, either borderline or malignant. However, the risk of recurrence of BOTs is somewhat controversial. We intended to find out the specific characteristics and prognosis of the recurrence of BOTs. Between 1995 and 2012, 130 women were diagnosed with BOTs at a single institution. Eleven patients diagnosed and treated for the recurrence of BOTs including seven cancerous and four borderline relapses were included for the analysis in this retrospective study. Clinicopathological characteristics and surgical procedures as well as follow-up data with overall survival were assessed. Statistical analyses was performed using the χ(2) test, t-test and log-rank test with Cox regression. One hundred and thirty patients with mean follow-up of 65.8 months were evaluated, of whom half were below 40 years old at their first diagnosis of BOTs. Among 11 recurrent cases (8.5%), 7 cancerous transformations (5.4%) and 4 borderline recurrences (3.1%) were detected with median time of 6 and 71 months after the primary surgery, respectively. Nine out of 11 recurrences were happened at their equal or below 40-years-old age at the primary di...Continue Reading

References

Jul 1, 1990·Gynecologic Oncology·N NakashimaJ Takeuchi
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ZanettaC Mangioni
Jun 25, 2002·Gynecologic Oncology·Cornelia Liu TrimbleEdward L Trimble
Aug 7, 2004·Gynecologic Oncology·Andrea ManeoFabio Landoni
Jan 18, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R FauvetE Daraï
Jul 27, 2005·Gynecologic Oncology·Patrice DesfeuxFabrice Lécuru
Nov 26, 2005·Gynecologic Oncology·Cesare RomagnoloTiziano Maggino
Oct 26, 2006·The American Journal of Surgical Pathology·Elvio G SilvaMichael Deavers
Apr 28, 2007·Acta Obstetricia Et Gynecologica Scandinavica·Elin ØdegaardMathias Onsrud
Jan 28, 2009·Gynecologic Oncology·Jeong-Yeol ParkJoo-Hyun Nam
May 30, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Miriam S LenhardAlexander Burges
Jun 2, 2009·Gynecologic Oncology·Tzu-I WuChyong-Huey Lai
Apr 14, 2010·Current Opinion in Obstetrics & Gynecology·Joo-Hyun Nam
Jul 18, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Annamaria FerreroPierandrea De Iaco
Jan 9, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Andreas ObermairMonika Janda
Jan 25, 2013·World Journal of Surgical Oncology·Margarita RomeoJoaquim Radua
Mar 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andreas du BoisUNKNOWN Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group

❮ Previous
Next ❯

Citations

May 12, 2016·Gynecologic Oncology·Nikoline Marie Schou KarlsenClaus Høgdall
Jul 19, 2016·Cancer Treatment Reviews·Giorgia MangiliFedro Peccatori
Oct 21, 2016·Journal of Ovarian Research·Mehmet GokcuAteş Karateke
May 14, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Piotr SobiczewskiBeata Śpiewankiewicz
Sep 26, 2015·Journal of Gynecologic Oncology·Seok Ju SeongTaejong Song
Jun 20, 2020·Archives of Gynecology and Obstetrics·Ori TalRon Sagiv

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

La Tunisie médicale
Tarak DamakKhaled Rahal
Experimental Oncology
V S SvintsitskiyJ G Tkalya
European Journal of Gynaecological Oncology
C NumanogluA Akyol
© 2021 Meta ULC. All rights reserved